Evidence map›Paper›PMID 23763754›Full record

ArticleEmerging infectious diseases2013

Multidrug-resistant atypical variants of Shigella flexneri in China.

Shaofu Qiu, Yong Wang, Xuebin Xu, Peng Li, Rongzhang Hao, Chaojie Yang, Nan Liu, Zhenjun Li, Zhongqiang Wang, Jian Wang and 9 more

Abstract read
In one paragraph

Article in Emerging infectious diseases, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. AnalyzingInfection and drug resistance · 2025
    Article
  3. Article
  4. Toward aInternational journal of molecular sciences · 2023
    Review
  5. Article
  6. Clonal serotype 1c multidrug-resistantFrontiers in medicine · 2022
    Article
  7. Article
  8. Infection and drug resistance · 2019
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Shaofu QiuAcademy of Military Medical Sciences, Beijing, China.
Yong Wang
Xuebin Xu
Peng Li
Rongzhang Hao
Chaojie Yang
Nan Liu
Zhenjun Li
Zhongqiang Wang
Jian Wang
Zhihao Wu
Wenli Su
Guang Yang
Huiming Jin
Ligui Wang
Yansong Sun
Zhengan Yuan
Liuyu Huang
Hongbin Song

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We identified 3 atypical Shigella flexneri varieties in China, including 92 strains with multidrug resistance, distinct pulse types, and a novel sequence type. Atypical varieties were prevalent mainly in developed regions, and 1 variant has become the dominant Shigella spp. serotype in China. Improved surveillance will help guide the prevention and control of shigellosis.

Indexed as

Drug Resistance, Multiple, BacterialAnti-Bacterial AgentsChinaDisk Diffusion Antimicrobial TestsDysentery, BacillaryFecesHumansMultilocus Sequence TypingShigella flexneriAnti-Bacterial Agentsantimicrobial resistanceatypicalbacteriaChinadiarrheal diseaseenteric infectionsgram-negative bacteriamultidrug resistancepulse typesequence typeShigella flexnerishigellosisvariants

Identifiers

PMID23763754
PMCPMC3713959

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.